TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $100,279,000 | +44.6% | 100,783,000 | +42.4% | 6.28% | +0.1% |
| Q3 2020 | $69,363,000 | +137.6% | 70,783,000 | +134.8% | 6.27% | +56.6% |
| Q2 2020 | $29,198,000 | +99.4% | 30,151,000 | +90.6% | 4.00% | +45.5% |
| Q1 2020 | $14,645,000 | – | 15,823,000 | – | 2.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Southpaw Asset Management LP | 20,000,000 | $17,675,000 | 25.38% |
| INCOME RESEARCH & MANAGEMENT | 23,109,000 | $20,278,000 | 5.29% |
| Fore Capital, LLC | 5,000,000 | $4,430,000 | 1.71% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 20,000,000 | $17,603,000 | 0.74% |
| ARISTEIA CAPITAL, L.L.C. | 18,500,000 | $16,361,000 | 0.70% |
| ZAZOVE ASSOCIATES LLC | 11,153,000 | $9,843,000 | 0.58% |
| BASSO CAPITAL MANAGEMENT, L.P. | 3,600,000 | $3,182,000 | 0.52% |
| CSS LLC/IL | 10,450,000 | $9,240,000 | 0.45% |
| Lombard Odier Asset Management (Europe) Ltd | 7,950,000 | $7,038,000 | 0.44% |
| Wellesley Asset Management | 6,740 | $5,948,000 | 0.31% |